Climb Bio
Climb Bio's Overview
Climb Therapeutics is a clinical-stage biopharmaceutical company dedicated to discovering and developing novel, pathogen-specific targeted medicines. Their primary focus is on addressing serious and life-threatening infectious diseases with significant unmet medical needs. By leveraging innovative approaches, Climb Therapeutics aims to provide better treatment options for patients globally.
Where is Climb Bio's Headquarters?
HQ Function
The headquarters serves as the central hub for research and development, clinical operations, and corporate administration.
Notable Features:
Modern laboratory and office facilities situated within a prominent biotech cluster, designed to foster innovation and collaboration.
Work Culture:
Climb Therapeutics fosters a collaborative, science-driven, and mission-focused work environment. The culture emphasizes innovation, scientific rigor, and a dedication to addressing critical patient needs in infectious diseases.
HQ Significance:
Its strategic location in South San Francisco provides access to a rich ecosystem of talent, research institutions, and potential partners, crucial for a biotech company focused on cutting-edge R&D.
Values Reflected in HQ: The headquarters' setup reflects values of innovation, precision, collaboration, and a commitment to advancing scientific frontiers in medicine.
Location:
As a clinical-stage biopharmaceutical company, Climb Therapeutics's global presence is primarily defined by its clinical trial activities, which may involve sites in various countries. The company collaborates with international partners and contract research organizations (CROs) to conduct its research and development programs. While its physical operations are centered in the US, its impact and collaborations aim for global reach in addressing infectious diseases.
Street Address:
611 Gateway Blvd, Suite 120
City:
South San Francisco
State/Province:
CA
Country:
USA
Climb Bio's Global Presence
Buying Intent Signals for Climb Bio
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Climb Bio
As of April 2025, Climb Bio' leadership includes:
Investors of Climb Bio
Climb Bio has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Climb Therapeutics has maintained a stable core leadership team focused on advancing its pipeline. The role of Head of R&D is currently filled on an interim basis by Steven L. Projan, PhD, indicating ongoing strategic team structuring. No major executive hires or departures have been publicly announced in the immediate last 12 months (mid-2023 to mid-2024).
Technology (Tech Stack) used by Climb Bio
Discover the tools Climb Bio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Climb Bio Email Formats and Examples
Climb Therapeutics likely uses a standard corporate email format. Based on common practices in the biotech industry, the most probable format is combining the first initial and last name.
firstinitiallast@climbtherapeutics.com
Format
jdoe@climbtherapeutics.com
Example
90%
Success rate
News and media
Business Wire • March 26, 2024
Climb Therapeutics Doses First Patient in Phase 1 Clinical Trial of CBM-001, a Novel Investigational Biologic for the Treatment of Moderate-to-Severe Atopic Dermatitis
Climb Therapeutics announced the dosing of the first patient in its Phase 1 clinical trial of CBM-001, an investigational biologic. The trial will evaluate the safety, tolerability, and pharmacokinetics of CBM-001 in healthy volunteers and patients with moderate-to-severe atopic dermatitis....more
Climb Therapeutics News • January 4, 2024
Climb Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference
Climb Therapeutics announced its participation and presentation at the H.C. Wainwright BioConnect Investor Conference, providing an update on its programs and corporate strategy to the investment community....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Climb Bio, are just a search away.